Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-I Wang

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Plos Pathogens|December 7, 2011
Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutantsChia Yin Lee, Yiu-Wing Kam, Jan Fric, et al.
Ebiomedicine|September 16, 2016
Plasmablasts During Acute Dengue Infection Represent a Small Subset of a Broader Virus-specific Memory B Cell PoolRamapraba Appanna, Srinivasan Kg, Mei Hui Xu, et al.
Iscience|June 16, 2025
A combinatorial and computational Tandem approach towards a universal therapeutics against ACE2-mediated coronavirus infectionsChia Yin Lee, Ching-Wen Huang, Louis De Falco, et al.
Nature Communications|November 1, 2023
Defining neutralization and allostery by antibodies against COVID-19 variantsNikhil Kumar Tulsian, Raghuvamsi Venkata Palur, Xinlei Qian, et al.
Mabs|March 16, 2022
Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variantsTaichi Kuramochi, Siok Wan Gan, Adrian W S Ho, et al.
Molecular Cancer Therapeutics|June 23, 2021
Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T CellsWen-Hsin Sandy Lee, Zhiyong Ye, Alice M S Cheung, et al.
JCI Insight|April 20, 2017
Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infectionsYiu-Wing Kam, Cheryl Yi-Pin Lee, Teck-Hui Teo, et al.
NPJ Vaccines|October 26, 2021
Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in SingaporeBei Wang, Yun Shan Goh, Tessa Prince, et al.
Cancer Immunology, Immunotherapy : CII|March 17, 2022
Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptorsMukul Prasad, Sashigala Ponnalagu, Qun Zeng, et al.
Scientific Reports|May 5, 2026
Optimizing mouse models for mRNA vaccines: addressing dose translation challengesZi Wei Chang, Yong Jie Tan, Yiyu Liao, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Plos Pathogens|December 7, 2011
Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutantsChia Yin Lee, Yiu-Wing Kam, Jan Fric, et al.
Ebiomedicine|September 16, 2016
Plasmablasts During Acute Dengue Infection Represent a Small Subset of a Broader Virus-specific Memory B Cell PoolRamapraba Appanna, Srinivasan Kg, Mei Hui Xu, et al.
Iscience|June 16, 2025
A combinatorial and computational Tandem approach towards a universal therapeutics against ACE2-mediated coronavirus infectionsChia Yin Lee, Ching-Wen Huang, Louis De Falco, et al.
Nature Communications|November 1, 2023
Defining neutralization and allostery by antibodies against COVID-19 variantsNikhil Kumar Tulsian, Raghuvamsi Venkata Palur, Xinlei Qian, et al.
Mabs|March 16, 2022
Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variantsTaichi Kuramochi, Siok Wan Gan, Adrian W S Ho, et al.
Molecular Cancer Therapeutics|June 23, 2021
Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T CellsWen-Hsin Sandy Lee, Zhiyong Ye, Alice M S Cheung, et al.
JCI Insight|April 20, 2017
Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infectionsYiu-Wing Kam, Cheryl Yi-Pin Lee, Teck-Hui Teo, et al.
NPJ Vaccines|October 26, 2021
Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in SingaporeBei Wang, Yun Shan Goh, Tessa Prince, et al.
Cancer Immunology, Immunotherapy : CII|March 17, 2022
Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptorsMukul Prasad, Sashigala Ponnalagu, Qun Zeng, et al.
Scientific Reports|May 5, 2026
Optimizing mouse models for mRNA vaccines: addressing dose translation challengesZi Wei Chang, Yong Jie Tan, Yiyu Liao, et al.
Pageof 6